CEL-SCI closes $5.7M at-the-market offering of 1.5M shares at $3.82

CEL SCI CORP

Gross proceeds ~$5.73M before placement agent fees (7%) and up to $95K expenses.
Shares sold at $3.82 under NYSE American rules; Offering closed July 14, 2025.
Proceeds to fund continued development of Multikine, general corporate purposes, and working capital.
Directors and officers subject to 45-day lock-up; company has 30-day issuance restriction.
ThinkEquity acted as sole placement agent; offering under existing S-3 shelf registration.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.